Paloma Partners Management CO Incyte Corp Transaction History

Paloma Partners Management CO

$3.08 Billion
Q3 2024

A detailed history of Paloma Partners Management CO transactions in Incyte Corp stock. As of the latest transaction made, Paloma Partners Management CO holds 7,000 shares of INCY stock, worth $493,780. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,000

Previous 8,300 15.66%

Holding current value

$493,780

Previous $503,000 8.15%

% of portfolio

0.01%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$57.33 - $68.61 $74,529 - $89,193	-1,300 Reduced 15.66%	7,000 $462,000
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $424,794 - $529,125	8,300 New	8,300 $503,000
Q1 2023 May 15, 2023	BUY	$70.23 - $86.01 $709,955 - $869,475	10,109 Added 335.18%	13,125 $948,000
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $202,614 - $253,675	3,016 New	3,016 $242,000
Q2 2022 Aug 15, 2022	BUY	$66.18 - $83.18 $3.34 Million - $4.2 Million	50,500 New	50,500 $3.84 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $316,700 - $370,550	-5,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $343,350 - $420,100	5,000 New	5,000 $344,000
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $1.49 Million - $1.97 Million	-19,598 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $662,229 - $801,335	-8,202 Reduced 29.5%	19,598 $1.71 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $1.78 Million - $2.29 Million	20,882 Added 301.85%	27,800 $2.5 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $1.25 Million - $1.84 Million	-16,869 Reduced 70.92%	6,918 $719,000
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.78 Million - $2.42 Million	-28,156 Reduced 54.21%	23,787 $1.74 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $3.52 Million - $4.61 Million	48,126 Added 1260.83%	51,943 $4.54 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $88,039 - $104,602	1,209 Added 46.36%	3,817 $283,000
Q2 2019 Aug 14, 2019	SELL	$73.52 - $88.7 $3.67 Million - $4.43 Million	-49,954 Reduced 95.04%	2,608 $222,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $1.43 Million - $1.98 Million	22,461 Added 74.62%	52,562 $4.52 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $1.35 Million - $1.62 Million	23,121 Added 331.25%	30,101 $1.91 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $848,939 - $1.02 Million	-13,748 Reduced 66.33%	6,980 $482,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $2.26 Million - $2.87 Million	20,728	20,728 $2.42 Million

Others Institutions Holding INCY

# of Institutions

645

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.7B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account

Paloma Partners Management CO Incyte Corp Transaction History